Glucose-modified low density lipoprotein enhances human monocyte chemotaxis. (Q47693085)

4 February 2018

title

Glucose-modified low density lipoprotein enhances human monocyte chemotaxis. (English)

1 reference

4 February 2018

1 reference

1 reference

Millican SA

1

1 reference

4 February 2018

Schultz D

2

1 reference

4 February 2018

Bagga M

3

1 reference

4 February 2018

Coussons PJ

4

1 reference

4 February 2018

Müller K

5

1 reference

4 February 2018

Hunt JV

6

1 reference

4 February 2018

publication date

1 May 1998

1 reference

4 February 2018

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Free Radical Research

1 reference

4 February 2018

volume

28

1 reference

4 February 2018

issue

5

1 reference

4 February 2018

page(s)

533-542

1 reference

4 February 2018

Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Role of oxidized low density lipoprotein in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Glucose oxidation and low-density lipoprotein-induced macrophage ceroid accumulation: possible implications for diabetic atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Toxicity of oxysterols to human monocyte-macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Deferoxamine therapy in high-ferritin diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Protein oxidation and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Role of oxidative stress in development of complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Oxidative glycation and free radical production: a causal mechanism of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Aminoguanidine has both pro-oxidant and antioxidant activity toward LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769809066890

10.3109/10715769809066890

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

9702533

1 reference

4 February 2018